nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2D6—Hydroxyurea—head and neck cancer	0.198	0.449	CbGbCtD
Mexiletine—CYP1A2—Fluorouracil—head and neck cancer	0.0917	0.208	CbGbCtD
Mexiletine—CYP2D6—Vinblastine—head and neck cancer	0.07	0.159	CbGbCtD
Mexiletine—CYP3A4—Vinblastine—head and neck cancer	0.0445	0.101	CbGbCtD
Mexiletine—CYP3A4—Docetaxel—head and neck cancer	0.0367	0.0833	CbGbCtD
Mexiletine—Speech impairment NOS—Fluorouracil—head and neck cancer	0.0207	0.0515	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Hydroxyurea—head and neck cancer	0.0143	0.0355	CcSEcCtD
Mexiletine—Lung infiltration—Hydroxyurea—head and neck cancer	0.0134	0.0333	CcSEcCtD
Mexiletine—Peptic ulcer—Vinblastine—head and neck cancer	0.0103	0.0256	CcSEcCtD
Mexiletine—Nystagmus—Vinblastine—head and neck cancer	0.00966	0.024	CcSEcCtD
Mexiletine—Oesophageal ulcer—Docetaxel—head and neck cancer	0.00896	0.0223	CcSEcCtD
Mexiletine—Numbness—Vinblastine—head and neck cancer	0.00832	0.0207	CcSEcCtD
Mexiletine—Sensory loss—Vinblastine—head and neck cancer	0.00796	0.0198	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Docetaxel—head and neck cancer	0.00743	0.0185	CcSEcCtD
Mexiletine—Heartburn—Fluorouracil—head and neck cancer	0.00658	0.0163	CcSEcCtD
Mexiletine—Nystagmus—Fluorouracil—head and neck cancer	0.00634	0.0158	CcSEcCtD
Mexiletine—Numbness—Fluorouracil—head and neck cancer	0.00546	0.0136	CcSEcCtD
Mexiletine—Speech disorder—Fluorouracil—head and neck cancer	0.00527	0.0131	CcSEcCtD
Mexiletine—Sensory loss—Fluorouracil—head and neck cancer	0.00523	0.013	CcSEcCtD
Mexiletine—Heartburn—Docetaxel—head and neck cancer	0.00475	0.0118	CcSEcCtD
Mexiletine—Angina pectoris—Vinblastine—head and neck cancer	0.00422	0.0105	CcSEcCtD
Mexiletine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00387	0.00962	CcSEcCtD
Mexiletine—Depression—Vinblastine—head and neck cancer	0.00385	0.00956	CcSEcCtD
Mexiletine—Neutropenia—Hydroxyurea—head and neck cancer	0.00369	0.00917	CcSEcCtD
Mexiletine—Agranulocytosis—Vinblastine—head and neck cancer	0.0036	0.00895	CcSEcCtD
Mexiletine—Drowsiness—Hydroxyurea—head and neck cancer	0.00352	0.00874	CcSEcCtD
Mexiletine—Amnesia—Fluorouracil—head and neck cancer	0.0035	0.00869	CcSEcCtD
Mexiletine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00345	0.00856	CcSEcCtD
Mexiletine—Pharyngitis—Vinblastine—head and neck cancer	0.00344	0.00854	CcSEcCtD
Mexiletine—Hallucination—Hydroxyurea—head and neck cancer	0.00314	0.00781	CcSEcCtD
Mexiletine—Ataxia—Fluorouracil—head and neck cancer	0.00309	0.00768	CcSEcCtD
Mexiletine—Alopecia—Vinblastine—head and neck cancer	0.00306	0.00761	CcSEcCtD
Mexiletine—Dry skin—Fluorouracil—head and neck cancer	0.00301	0.00749	CcSEcCtD
Mexiletine—Lightheadedness—Docetaxel—head and neck cancer	0.00292	0.00727	CcSEcCtD
Mexiletine—Dysphagia—Fluorouracil—head and neck cancer	0.00284	0.00706	CcSEcCtD
Mexiletine—Ill-defined disorder—Vinblastine—head and neck cancer	0.0028	0.00695	CcSEcCtD
Mexiletine—Alopecia—Hydroxyurea—head and neck cancer	0.00279	0.00694	CcSEcCtD
Mexiletine—Angina pectoris—Fluorouracil—head and neck cancer	0.00277	0.00688	CcSEcCtD
Mexiletine—Malaise—Vinblastine—head and neck cancer	0.00272	0.00676	CcSEcCtD
Mexiletine—Leukopenia—Vinblastine—head and neck cancer	0.0027	0.00671	CcSEcCtD
Mexiletine—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00262	0.0065	CcSEcCtD
Mexiletine—Convulsion—Vinblastine—head and neck cancer	0.00261	0.00649	CcSEcCtD
Mexiletine—Hypertension—Vinblastine—head and neck cancer	0.0026	0.00647	CcSEcCtD
Mexiletine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00255	0.00634	CcSEcCtD
Mexiletine—Discomfort—Vinblastine—head and neck cancer	0.00254	0.0063	CcSEcCtD
Mexiletine—Hot flush—Docetaxel—head and neck cancer	0.00254	0.0063	CcSEcCtD
Mexiletine—Menopausal symptoms—Docetaxel—head and neck cancer	0.00251	0.00625	CcSEcCtD
Mexiletine—Visual disturbance—Docetaxel—head and neck cancer	0.0025	0.00622	CcSEcCtD
Mexiletine—Malaise—Hydroxyurea—head and neck cancer	0.00248	0.00616	CcSEcCtD
Mexiletine—Leukopenia—Hydroxyurea—head and neck cancer	0.00246	0.00612	CcSEcCtD
Mexiletine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00241	0.00599	CcSEcCtD
Mexiletine—Convulsion—Hydroxyurea—head and neck cancer	0.00238	0.00592	CcSEcCtD
Mexiletine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00236	0.00587	CcSEcCtD
Mexiletine—Discomfort—Hydroxyurea—head and neck cancer	0.00231	0.00575	CcSEcCtD
Mexiletine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00226	0.00562	CcSEcCtD
Mexiletine—Pharyngitis—Fluorouracil—head and neck cancer	0.00226	0.00561	CcSEcCtD
Mexiletine—Oedema—Hydroxyurea—head and neck cancer	0.00224	0.00558	CcSEcCtD
Mexiletine—Ataxia—Docetaxel—head and neck cancer	0.00223	0.00554	CcSEcCtD
Mexiletine—Paraesthesia—Vinblastine—head and neck cancer	0.00221	0.00549	CcSEcCtD
Mexiletine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0022	0.00546	CcSEcCtD
Mexiletine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00219	0.00544	CcSEcCtD
Mexiletine—Dry skin—Docetaxel—head and neck cancer	0.00217	0.0054	CcSEcCtD
Mexiletine—Cramp muscle—Docetaxel—head and neck cancer	0.00214	0.00531	CcSEcCtD
Mexiletine—Constipation—Vinblastine—head and neck cancer	0.0021	0.00523	CcSEcCtD
Mexiletine—Pain—Vinblastine—head and neck cancer	0.0021	0.00523	CcSEcCtD
Mexiletine—Dysphagia—Docetaxel—head and neck cancer	0.00205	0.0051	CcSEcCtD
Mexiletine—Arrhythmia—Fluorouracil—head and neck cancer	0.00203	0.00505	CcSEcCtD
Mexiletine—Feeling abnormal—Vinblastine—head and neck cancer	0.00203	0.00504	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00201	0.005	CcSEcCtD
Mexiletine—Alopecia—Fluorouracil—head and neck cancer	0.00201	0.00499	CcSEcCtD
Mexiletine—Dyspnoea—Hydroxyurea—head and neck cancer	0.002	0.00497	CcSEcCtD
Mexiletine—Angina pectoris—Docetaxel—head and neck cancer	0.002	0.00496	CcSEcCtD
Mexiletine—Somnolence—Hydroxyurea—head and neck cancer	0.002	0.00496	CcSEcCtD
Mexiletine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00198	0.00491	CcSEcCtD
Mexiletine—Abdominal pain—Vinblastine—head and neck cancer	0.00195	0.00483	CcSEcCtD
Mexiletine—Fatigue—Hydroxyurea—head and neck cancer	0.00194	0.00481	CcSEcCtD
Mexiletine—Constipation—Hydroxyurea—head and neck cancer	0.00192	0.00477	CcSEcCtD
Mexiletine—Pain—Hydroxyurea—head and neck cancer	0.00192	0.00477	CcSEcCtD
Mexiletine—Neutropenia—Docetaxel—head and neck cancer	0.00192	0.00476	CcSEcCtD
Mexiletine—Vision blurred—Fluorouracil—head and neck cancer	0.00187	0.00464	CcSEcCtD
Mexiletine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00185	0.0046	CcSEcCtD
Mexiletine—Hypersensitivity—Vinblastine—head and neck cancer	0.00181	0.00451	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00181	0.0045	CcSEcCtD
Mexiletine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00177	0.00441	CcSEcCtD
Mexiletine—Leukopenia—Fluorouracil—head and neck cancer	0.00177	0.0044	CcSEcCtD
Mexiletine—Asthenia—Vinblastine—head and neck cancer	0.00177	0.00439	CcSEcCtD
Mexiletine—Convulsion—Fluorouracil—head and neck cancer	0.00172	0.00426	CcSEcCtD
Mexiletine—Agranulocytosis—Docetaxel—head and neck cancer	0.00171	0.00424	CcSEcCtD
Mexiletine—Chest pain—Fluorouracil—head and neck cancer	0.00169	0.00419	CcSEcCtD
Mexiletine—Diarrhoea—Vinblastine—head and neck cancer	0.00168	0.00418	CcSEcCtD
Mexiletine—Discomfort—Fluorouracil—head and neck cancer	0.00167	0.00414	CcSEcCtD
Mexiletine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00165	0.00411	CcSEcCtD
Mexiletine—Hepatitis—Docetaxel—head and neck cancer	0.00164	0.00408	CcSEcCtD
Mexiletine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00163	0.00406	CcSEcCtD
Mexiletine—Confusional state—Fluorouracil—head and neck cancer	0.00163	0.00405	CcSEcCtD
Mexiletine—Pharyngitis—Docetaxel—head and neck cancer	0.00163	0.00405	CcSEcCtD
Mexiletine—Dizziness—Vinblastine—head and neck cancer	0.00163	0.00404	CcSEcCtD
Mexiletine—Oedema—Fluorouracil—head and neck cancer	0.00162	0.00401	CcSEcCtD
Mexiletine—Asthenia—Hydroxyurea—head and neck cancer	0.00161	0.004	CcSEcCtD
Mexiletine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00158	0.00393	CcSEcCtD
Mexiletine—Visual impairment—Docetaxel—head and neck cancer	0.00158	0.00393	CcSEcCtD
Mexiletine—Vomiting—Vinblastine—head and neck cancer	0.00156	0.00389	CcSEcCtD
Mexiletine—Erythema multiforme—Docetaxel—head and neck cancer	0.00155	0.00386	CcSEcCtD
Mexiletine—Headache—Vinblastine—head and neck cancer	0.00154	0.00383	CcSEcCtD
Mexiletine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00154	0.00382	CcSEcCtD
Mexiletine—Hypotension—Fluorouracil—head and neck cancer	0.00151	0.00375	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—TYMS—head and neck cancer	0.0015	0.00958	CbGpPWpGaD
Mexiletine—Dizziness—Hydroxyurea—head and neck cancer	0.00148	0.00369	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00147	0.00366	CcSEcCtD
Mexiletine—Arrhythmia—Docetaxel—head and neck cancer	0.00147	0.00364	CcSEcCtD
Mexiletine—Nausea—Vinblastine—head and neck cancer	0.00146	0.00363	CcSEcCtD
Mexiletine—Paraesthesia—Fluorouracil—head and neck cancer	0.00145	0.0036	CcSEcCtD
Mexiletine—Alopecia—Docetaxel—head and neck cancer	0.00145	0.0036	CcSEcCtD
Mexiletine—Dyspnoea—Fluorouracil—head and neck cancer	0.00144	0.00358	CcSEcCtD
Mexiletine—Somnolence—Fluorouracil—head and neck cancer	0.00144	0.00357	CcSEcCtD
Mexiletine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00144	0.00916	CbGpPWpGaD
Mexiletine—Vomiting—Hydroxyurea—head and neck cancer	0.00143	0.00355	CcSEcCtD
Mexiletine—Dyspepsia—Fluorouracil—head and neck cancer	0.00142	0.00353	CcSEcCtD
Mexiletine—Rash—Hydroxyurea—head and neck cancer	0.00142	0.00352	CcSEcCtD
Mexiletine—Dermatitis—Hydroxyurea—head and neck cancer	0.00141	0.00351	CcSEcCtD
Mexiletine—Headache—Hydroxyurea—head and neck cancer	0.00141	0.00349	CcSEcCtD
Mexiletine—Dysgeusia—Docetaxel—head and neck cancer	0.0014	0.00348	CcSEcCtD
Mexiletine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00139	0.00884	CbGpPWpGaD
Mexiletine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00139	0.00884	CbGpPWpGaD
Mexiletine—Pain—Fluorouracil—head and neck cancer	0.00138	0.00343	CcSEcCtD
Mexiletine—Muscle spasms—Docetaxel—head and neck cancer	0.00137	0.00341	CcSEcCtD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—head and neck cancer	0.00137	0.00872	CbGpPWpGaD
Mexiletine—Nausea—Hydroxyurea—head and neck cancer	0.00133	0.00331	CcSEcCtD
Mexiletine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00133	0.00331	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.00129	0.00823	CbGpPWpGaD
Mexiletine—Syncope—Docetaxel—head and neck cancer	0.00128	0.00318	CcSEcCtD
Mexiletine—Leukopenia—Docetaxel—head and neck cancer	0.00128	0.00318	CcSEcCtD
Mexiletine—Body temperature increased—Fluorouracil—head and neck cancer	0.00128	0.00317	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.00128	0.00814	CbGpPWpGaD
Mexiletine—Palpitations—Docetaxel—head and neck cancer	0.00126	0.00314	CcSEcCtD
Mexiletine—Loss of consciousness—Docetaxel—head and neck cancer	0.00126	0.00312	CcSEcCtD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00125	0.008	CbGpPWpGaD
Mexiletine—Convulsion—Docetaxel—head and neck cancer	0.00124	0.00308	CcSEcCtD
Mexiletine—Hypertension—Docetaxel—head and neck cancer	0.00123	0.00307	CcSEcCtD
Mexiletine—Chest pain—Docetaxel—head and neck cancer	0.00122	0.00302	CcSEcCtD
Mexiletine—Arthralgia—Docetaxel—head and neck cancer	0.00122	0.00302	CcSEcCtD
Mexiletine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00119	0.00296	CcSEcCtD
Mexiletine—Dry mouth—Docetaxel—head and neck cancer	0.00119	0.00296	CcSEcCtD
Mexiletine—Confusional state—Docetaxel—head and neck cancer	0.00118	0.00292	CcSEcCtD
Mexiletine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00117	0.00749	CbGpPWpGaD
Mexiletine—Oedema—Docetaxel—head and neck cancer	0.00117	0.0029	CcSEcCtD
Mexiletine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.00116	0.0074	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CEBPA—head and neck cancer	0.00115	0.00736	CbGpPWpGaD
Mexiletine—Shock—Docetaxel—head and neck cancer	0.00115	0.00285	CcSEcCtD
Mexiletine—Thrombocytopenia—Docetaxel—head and neck cancer	0.00114	0.00284	CcSEcCtD
Mexiletine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00113	0.00719	CbGpPWpGaD
Mexiletine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00111	0.00711	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.00111	0.00707	CbGpPWpGaD
Mexiletine—Diarrhoea—Fluorouracil—head and neck cancer	0.00111	0.00275	CcSEcCtD
Mexiletine—Hypotension—Docetaxel—head and neck cancer	0.00109	0.00271	CcSEcCtD
Mexiletine—Dizziness—Fluorouracil—head and neck cancer	0.00107	0.00265	CcSEcCtD
Mexiletine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.00107	0.00682	CbGpPWpGaD
Mexiletine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00106	0.00264	CcSEcCtD
Mexiletine—SCN2A—Developmental Biology—CEBPA—head and neck cancer	0.00106	0.00677	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CEBPA—head and neck cancer	0.00106	0.00677	CbGpPWpGaD
Mexiletine—Paraesthesia—Docetaxel—head and neck cancer	0.00105	0.0026	CcSEcCtD
Mexiletine—Dyspnoea—Docetaxel—head and neck cancer	0.00104	0.00258	CcSEcCtD
Mexiletine—Somnolence—Docetaxel—head and neck cancer	0.00104	0.00258	CcSEcCtD
Mexiletine—Vomiting—Fluorouracil—head and neck cancer	0.00103	0.00255	CcSEcCtD
Mexiletine—Dyspepsia—Docetaxel—head and neck cancer	0.00103	0.00255	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—CEBPA—head and neck cancer	0.00102	0.00652	CbGpPWpGaD
Mexiletine—Rash—Fluorouracil—head and neck cancer	0.00102	0.00253	CcSEcCtD
Mexiletine—Dermatitis—Fluorouracil—head and neck cancer	0.00102	0.00253	CcSEcCtD
Mexiletine—Headache—Fluorouracil—head and neck cancer	0.00101	0.00251	CcSEcCtD
Mexiletine—Fatigue—Docetaxel—head and neck cancer	0.00101	0.0025	CcSEcCtD
Mexiletine—Constipation—Docetaxel—head and neck cancer	0.000997	0.00248	CcSEcCtD
Mexiletine—Pain—Docetaxel—head and neck cancer	0.000997	0.00248	CcSEcCtD
Mexiletine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000982	0.00626	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000968	0.00618	CbGpPWpGaD
Mexiletine—Feeling abnormal—Docetaxel—head and neck cancer	0.000961	0.00239	CcSEcCtD
Mexiletine—Nausea—Fluorouracil—head and neck cancer	0.00096	0.00238	CcSEcCtD
Mexiletine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000954	0.00237	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000951	0.00607	CbGpPWpGaD
Mexiletine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000944	0.00603	CbGpPWpGaD
Mexiletine—AHR—Adipogenesis—STAT3—head and neck cancer	0.000925	0.0059	CbGpPWpGaD
Mexiletine—Body temperature increased—Docetaxel—head and neck cancer	0.000922	0.00229	CcSEcCtD
Mexiletine—Abdominal pain—Docetaxel—head and neck cancer	0.000922	0.00229	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000918	0.00585	CbGpPWpGaD
Mexiletine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000906	0.00578	CbGpPWpGaD
Mexiletine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00087	0.00555	CbGpPWpGaD
Mexiletine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000861	0.00549	CbGpPWpGaD
Mexiletine—Hypersensitivity—Docetaxel—head and neck cancer	0.000859	0.00213	CcSEcCtD
Mexiletine—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000839	0.00535	CbGpPWpGaD
Mexiletine—Asthenia—Docetaxel—head and neck cancer	0.000837	0.00208	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000829	0.00529	CbGpPWpGaD
Mexiletine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000825	0.00526	CbGpPWpGaD
Mexiletine—Diarrhoea—Docetaxel—head and neck cancer	0.000798	0.00198	CcSEcCtD
Mexiletine—Dizziness—Docetaxel—head and neck cancer	0.000771	0.00192	CcSEcCtD
Mexiletine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000758	0.00484	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—MAPK3—head and neck cancer	0.000755	0.00482	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000746	0.00476	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000746	0.00476	CbGpPWpGaD
Mexiletine—Vomiting—Docetaxel—head and neck cancer	0.000741	0.00184	CcSEcCtD
Mexiletine—Rash—Docetaxel—head and neck cancer	0.000735	0.00183	CcSEcCtD
Mexiletine—Dermatitis—Docetaxel—head and neck cancer	0.000735	0.00183	CcSEcCtD
Mexiletine—Headache—Docetaxel—head and neck cancer	0.000731	0.00182	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—PTEN—head and neck cancer	0.00073	0.00466	CbGpPWpGaD
Mexiletine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000729	0.00465	CbGpPWpGaD
Mexiletine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000729	0.00465	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CEBPA—head and neck cancer	0.000719	0.00459	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—MAPK1—head and neck cancer	0.000718	0.00458	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—EGFR—head and neck cancer	0.000718	0.00458	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—MAPK3—head and neck cancer	0.000694	0.00443	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—MAPK3—head and neck cancer	0.000694	0.00443	CbGpPWpGaD
Mexiletine—Nausea—Docetaxel—head and neck cancer	0.000693	0.00172	CcSEcCtD
Mexiletine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000693	0.00442	CbGpPWpGaD
Mexiletine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000683	0.00436	CbGpPWpGaD
Mexiletine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000678	0.00433	CbGpPWpGaD
Mexiletine—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000669	0.00427	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—MAPK3—head and neck cancer	0.000669	0.00427	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—MAPK1—head and neck cancer	0.00066	0.00421	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—MAPK1—head and neck cancer	0.00066	0.00421	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—EGFR—head and neck cancer	0.00066	0.00421	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—EGFR—head and neck cancer	0.00066	0.00421	CbGpPWpGaD
Mexiletine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000643	0.0041	CbGpPWpGaD
Mexiletine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000641	0.00409	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—NAT2—head and neck cancer	0.000637	0.00406	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—MAPK1—head and neck cancer	0.000636	0.00406	CbGpPWpGaD
Mexiletine—SCN10A—L1CAM interactions—EGFR—head and neck cancer	0.000636	0.00406	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	0.000628	0.00401	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000626	0.004	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000624	0.00398	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000615	0.00393	CbGpPWpGaD
Mexiletine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000561	0.00358	CbGpPWpGaD
Mexiletine—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00055	0.00351	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000529	0.00337	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000504	0.00322	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000504	0.00322	CbGpPWpGaD
Mexiletine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000504	0.00322	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—head and neck cancer	0.000498	0.00318	CbGpPWpGaD
Mexiletine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000481	0.00307	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000477	0.00304	CbGpPWpGaD
Mexiletine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000475	0.00303	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000472	0.00301	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—MAPK3—head and neck cancer	0.00047	0.003	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—MAPK1—head and neck cancer	0.000447	0.00285	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—EGFR—head and neck cancer	0.000447	0.00285	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000443	0.00282	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000437	0.00279	CbGpPWpGaD
Mexiletine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000408	0.0026	CbGpPWpGaD
Mexiletine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000402	0.00257	CbGpPWpGaD
Mexiletine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00039	0.00249	CbGpPWpGaD
Mexiletine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000389	0.00248	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000375	0.00239	CbGpPWpGaD
Mexiletine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000373	0.00238	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.00037	0.00236	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NOTCH1—head and neck cancer	0.000368	0.00235	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NOTCH1—head and neck cancer	0.000338	0.00216	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NOTCH1—head and neck cancer	0.000338	0.00216	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000337	0.00215	CbGpPWpGaD
Mexiletine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000331	0.00211	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NOTCH1—head and neck cancer	0.000326	0.00208	CbGpPWpGaD
Mexiletine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000317	0.00202	CbGpPWpGaD
Mexiletine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000315	0.00201	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000315	0.00201	CbGpPWpGaD
Mexiletine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000311	0.00198	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.00031	0.00198	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000308	0.00197	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000304	0.00194	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—head and neck cancer	0.000302	0.00192	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.0003	0.00191	CbGpPWpGaD
Mexiletine—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000298	0.0019	CbGpPWpGaD
Mexiletine—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000294	0.00188	CbGpPWpGaD
Mexiletine—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.000292	0.00186	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000289	0.00185	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000288	0.00184	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000285	0.00182	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MAPK3—head and neck cancer	0.000285	0.00182	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000281	0.00179	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000278	0.00177	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—head and neck cancer	0.000277	0.00177	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—head and neck cancer	0.000277	0.00177	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—MAPK1—head and neck cancer	0.000271	0.00173	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—head and neck cancer	0.000271	0.00173	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—head and neck cancer	0.000267	0.0017	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—UROD—head and neck cancer	0.000262	0.00167	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MAPK3—head and neck cancer	0.000262	0.00167	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MAPK3—head and neck cancer	0.000262	0.00167	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—UROD—head and neck cancer	0.000257	0.00164	CbGpPWpGaD
Mexiletine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000255	0.00163	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MAPK3—head and neck cancer	0.000253	0.00161	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—MAPK1—head and neck cancer	0.000249	0.00159	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—MAPK1—head and neck cancer	0.000249	0.00159	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—head and neck cancer	0.000249	0.00159	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—head and neck cancer	0.000249	0.00159	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—MAPK1—head and neck cancer	0.000241	0.00153	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—head and neck cancer	0.00024	0.00153	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000236	0.00151	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NOTCH1—head and neck cancer	0.000229	0.00146	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000219	0.00139	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—head and neck cancer	0.000218	0.00139	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000216	0.00138	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—head and neck cancer	0.000215	0.00137	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—STAT3—head and neck cancer	0.000213	0.00136	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000213	0.00136	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000213	0.00136	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000213	0.00136	CbGpPWpGaD
Mexiletine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000207	0.00132	CbGpPWpGaD
Mexiletine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000204	0.0013	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MAPK3—head and neck cancer	0.000204	0.0013	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—head and neck cancer	0.0002	0.00128	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—head and neck cancer	0.0002	0.00128	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—head and neck cancer	0.000198	0.00126	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—head and neck cancer	0.000198	0.00126	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—STAT3—head and neck cancer	0.000196	0.00125	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—STAT3—head and neck cancer	0.000196	0.00125	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—MAPK1—head and neck cancer	0.000194	0.00124	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—head and neck cancer	0.000194	0.00124	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—head and neck cancer	0.000193	0.00123	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—head and neck cancer	0.000191	0.00122	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—STAT3—head and neck cancer	0.000189	0.0012	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—head and neck cancer	0.000188	0.0012	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MAPK3—head and neck cancer	0.000187	0.00119	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MAPK3—head and neck cancer	0.000187	0.00119	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000185	0.00118	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000183	0.00117	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—UROD—head and neck cancer	0.000182	0.00116	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MAPK3—head and neck cancer	0.00018	0.00115	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—MAPK1—head and neck cancer	0.000178	0.00114	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—MAPK1—head and neck cancer	0.000178	0.00114	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—head and neck cancer	0.000178	0.00114	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—head and neck cancer	0.000178	0.00114	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MAPK3—head and neck cancer	0.000178	0.00113	CbGpPWpGaD
Mexiletine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.000176	0.00112	CbGpPWpGaD
Mexiletine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000173	0.0011	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—MAPK1—head and neck cancer	0.000172	0.0011	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—head and neck cancer	0.000172	0.00109	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000171	0.00109	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—MAPK1—head and neck cancer	0.000169	0.00108	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—head and neck cancer	0.000169	0.00108	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—head and neck cancer	0.000156	0.000992	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—UROD—head and neck cancer	0.000154	0.000985	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000143	0.000912	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—head and neck cancer	0.000143	0.000912	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—head and neck cancer	0.000143	0.000912	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000141	0.000899	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—head and neck cancer	0.000138	0.000879	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—head and neck cancer	0.000137	0.000876	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—head and neck cancer	0.000136	0.000866	CbGpPWpGaD
Mexiletine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000136	0.000865	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	0.000134	0.000855	CbGpPWpGaD
Mexiletine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000134	0.000853	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—STAT3—head and neck cancer	0.000133	0.000847	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	0.000127	0.000809	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—head and neck cancer	0.000126	0.000805	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—head and neck cancer	0.000126	0.000805	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—head and neck cancer	0.000122	0.000776	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	0.000121	0.00077	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—head and neck cancer	0.000121	0.00077	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00012	0.000765	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UROD—head and neck cancer	0.000119	0.00076	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000109	0.000695	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000107	0.000681	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—head and neck cancer	9.69e-05	0.000618	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—DPYD—head and neck cancer	9.55e-05	0.000609	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—DPYD—head and neck cancer	9.36e-05	0.000597	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—YAP1—head and neck cancer	9.06e-05	0.000578	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—YAP1—head and neck cancer	8.88e-05	0.000566	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—head and neck cancer	8.55e-05	0.000546	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NAT2—head and neck cancer	7.57e-05	0.000483	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.81e-05	0.000435	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.74e-05	0.00043	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—DPYD—head and neck cancer	6.64e-05	0.000424	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT2—head and neck cancer	6.41e-05	0.000409	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—YAP1—head and neck cancer	6.3e-05	0.000402	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—DPYD—head and neck cancer	5.62e-05	0.000359	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—head and neck cancer	5.44e-05	0.000347	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—head and neck cancer	5.38e-05	0.000343	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—YAP1—head and neck cancer	5.34e-05	0.00034	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—head and neck cancer	5.33e-05	0.00034	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—head and neck cancer	5.27e-05	0.000336	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GPX1—head and neck cancer	5.15e-05	0.000329	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	5.1e-05	0.000325	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GPX1—head and neck cancer	5.05e-05	0.000322	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A1—head and neck cancer	5e-05	0.000319	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT2—head and neck cancer	4.95e-05	0.000316	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—DPYD—head and neck cancer	4.34e-05	0.000277	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—YAP1—head and neck cancer	4.12e-05	0.000263	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.01e-05	0.000256	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—head and neck cancer	3.78e-05	0.000241	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.74e-05	0.000239	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GPX1—head and neck cancer	3.58e-05	0.000228	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	3.54e-05	0.000226	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.5e-05	0.000223	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—head and neck cancer	3.2e-05	0.000204	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—head and neck cancer	3.17e-05	0.000202	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPX1—head and neck cancer	3.03e-05	0.000194	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—head and neck cancer	3.03e-05	0.000193	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3e-05	0.000192	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—head and neck cancer	2.97e-05	0.00019	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—head and neck cancer	2.65e-05	0.000169	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—head and neck cancer	2.59e-05	0.000165	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—head and neck cancer	2.47e-05	0.000158	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.47e-05	0.000157	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.44e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPX1—head and neck cancer	2.34e-05	0.000149	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.32e-05	0.000148	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.11e-05	0.000134	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.87e-05	0.000119	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.84e-05	0.000117	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—head and neck cancer	1.83e-05	0.000117	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.79e-05	0.000114	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.56e-05	9.94e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—head and neck cancer	1.52e-05	9.73e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—head and neck cancer	1.49e-05	9.53e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.38e-05	8.79e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.3e-05	8.27e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—head and neck cancer	1.2e-05	7.67e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.1e-05	7.01e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.06e-05	6.76e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—head and neck cancer	8.98e-06	5.73e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	8.48e-06	5.41e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—head and neck cancer	6.93e-06	4.42e-05	CbGpPWpGaD
